The Ministry of Industry and Trade outlined the measures of state support for the medical and pharmaceutical industries

---

On May 16, the RUSSIA EXPO held a thematic day "Modern Technologies for Health Preservation". The plenary session was dedicated to the national project for the development of modern medical technologies - "New Technologies for Health Preservation". Deputy Minister of Industry and Trade of the Russian Federation Ekaterina Priezzheva took part in the event.

The participants learned about the main results of the development of the medical and pharmaceutical industry and proposals to flesh out the new national project for the development of modern health preservation technologies. The development of the national project is being carried out on the instructions of the President of the Russian Federation Vladimir Putin.

Ekaterina Priezzheva, Deputy Head of the Ministry of Industry and Trade of Russia, said that since 2014, the market volume of medical products in value terms has increased by 2.5 times, in pharmaceuticals - by 1.5 times. She called the results in the field of import substitution one of the main achievements.

“In the growing markets, we have managed not only to maintain, but even to increase the share of domestic products. For example, in 2023, its share amounted to 28.5% in the medical industry and 36.8% in the pharmaceutical industry. In absolute terms, the growth was four times for medical devices and three and a half times for pharmaceuticals. The share of domestic medicines in physical terms as of 2023 is 63%. That is, two-thirds of products as of the end of the previous year are domestic,” emphasized Ekaterina Priezzheva, Deputy Head of the Ministry of Industry and Trade of Russia, adding that the average annual growth rate remains high and is currently more than 10%.

Ekaterina Priezzheva emphasized that such results became possible due to the measures of systematic state support provided to domestic manufacturers. The state provided support for 1,700 projects worth more than 227 billion rubles.

“Now, when we have already developed the necessary competencies and modernized production, it is necessary to focus on deepening localization in order to ensure the raw material independence of manufacturers, and focus on our own developments, localization of production, increasing the share of exports,” she said

In her speech, the deputy minister announced details of the implementation of such projects as the “Pharma-2030” strategy, the plan for the development of the medical industry until 2030, the new federal project “Industry for Healthcare”. Such goals as transition from import substitution to advancing over import, consistent deepening of localization, stimulation of domestic developments, increasing the share of exports and introduction of new locally produced goods into medical practice were named as benchmarks.

Ekaterina Priezzheva assured that the government, represented by the Russian Ministry of Industry and Trade, will consistently continue to support the medical and pharmaceutical industry, maintaining both existing measures and introducing new forms of assistance, the main content of which will be to facilitate access to investment and provide accelerated and facilitated access to sales markets.